Lessons for cancer drug treatment from tackling a non-cancerous overgrowth syndrome

Nature. 2018 Jun;558(7711):523-525. doi: 10.1038/d41586-018-05365-w.
No abstract available

Keywords: Cancer; Medical research.

Publication types

  • News
  • Comment

MeSH terms

  • Antineoplastic Agents*
  • Class I Phosphatidylinositol 3-Kinases
  • Humans
  • Neoplasms*
  • Phosphatidylinositol 3-Kinases
  • Syndrome

Substances

  • Antineoplastic Agents
  • Phosphatidylinositol 3-Kinases
  • Class I Phosphatidylinositol 3-Kinases
  • PIK3CA protein, human